Smartphone ultrasonography to improve diagnosis and treatment of life-threatening injuries for trauma patients in Cameroon
智能手机超声检查可改善喀麦隆创伤患者危及生命的损伤的诊断和治疗
基本信息
- 批准号:10741520
- 负责人:
- 金额:$ 16.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-17 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AreaBlindedCameroonCaringCellular PhoneCessation of lifeClinical Practice PatternsCollaborationsCompetenceConsultationsCountryData CollectionDeath RateDevelopmentDiagnosisDiagnosticDiagnostic ImagingEducationEducational CurriculumEffectivenessEquipmentFailureFutureGoalsHealthHealth systemHemorrhagic ShockHospitalsImageInjuryInterruptionInterventional UltrasonographyInterviewKnowledgeKnowledge acquisitionLifeMalariaMethodsMissionMobile Health ApplicationModalityOperative Surgical ProceduresOutcomePatientsPerformancePhasePopulationProceduresProviderPublic HealthRegistriesResearchScanningSiteStandardizationStructureSurveysTestingTimeTrainingTraumaTrauma patientTuberculosisUltrasonographyUnited States National Institutes of HealthValidationacceptability and feasibilitycloud basedcohortcostdesigndiagnostic accuracyeducation evaluationeffectiveness evaluationefficacy evaluationencryptionfeasibility testingimplementation facilitatorsimplementation protocolimprovedinjuredinjury burdenlow and middle-income countriesmHealthmortalityoperationpreventable deathprogramsradiologistresearch and developmentscale upsevere injuryskill acquisitionskillssystems researchtrauma careultrasound
项目摘要
Project Summary/Abstract
Diagnostic imaging is a standard part of trauma assessment, but access to imaging is often extremely limited
in low and middle-income countries, where most injury deaths occur. Trauma death rates in Cameroon are
higher than surrounding countries. Failure to diagnose hemorrhagic shock has been implicated in death
analysis of the Cameroon Trauma Registry and by the National Trauma Quality Improvement Committee as a
key root cause of preventable deaths. Currently, fewer than half of trauma patients in Cameroon receive
diagnostic imaging. Development of a provider-performed smartphone-based ultrasonography (SBU) program
for trauma could increase diagnostic access and facilitate timely diagnosis and treatment of injuries but only if it
is feasible and effective for the Cameroonian context. The long-term goal of this research is to reduce the
burden associated with injury in Cameroon. This study’s overall objective is to expand diagnostic capacity to
facilitate timely diagnosis of injury and reduce injury burden. The study hypothesis is that implementation of a
provider-performed SBU program is a feasible and effective method of expanding access to diagnostic imaging
for trauma patients in Cameroon. To accomplish the objective, this study will pursue three specific aims for the
R21 phase: 1) Evaluate the educational efficacy of a SBU training curriculum in short- and medium-term skill
and knowledge acquisition among Cameroonian trauma providers; 2) Evaluate the feasibility of a provider-
performed SBU pilot in Cameroon; 3) Assess the acceptability of an SBU pilot among Cameroonian trauma
stakeholders. If the R21 transition milestones are met, the R33 phase will pursue three specific aims: 1)
Assess diagnostic accuracy of provider-performed SBU on trauma patients; 2) Evaluate the effectiveness of a
provider-performed SBU program in expanding diagnostic capacity for trauma; 3) Test associations between
SBU program implementation and trauma outcomes. Validating SBU as a feasible and effective method to
expand diagnostic capacity will remove a major roadblock to prompt trauma care and provide a critical target
for reducing the detrimental impact of injury on this population. Embedded in the study approach is the training
of clinicians in health systems research and strengthening of mHEALTH capacity in Cameroon which will
support development and research across health sectors. A standardized SBU training and implementation
protocol could be rapidly scaled-up for wider implementation throughout Cameroon and validated in other
LMIC contexts.
项目摘要/摘要
诊断成像是创伤评估的标准部分,但获得成像的机会往往极其有限。
在低收入和中等收入国家,大多数伤害死亡发生在这些国家。喀麦隆的创伤死亡率是
高于周边国家。失血性休克的诊断失败与死亡有关
喀麦隆创伤登记处和国家创伤质量改进委员会的分析
可预防死亡的主要根本原因。目前,喀麦隆只有不到一半的创伤患者接受
诊断成像。开发由提供商执行的基于智能手机的超声检查(SBU)程序
因为创伤可以增加诊断机会,促进对伤害的及时诊断和治疗,但只有在
在喀麦隆的情况下是可行和有效的。这项研究的长期目标是减少
在喀麦隆,与伤病相关的负担。这项研究的总体目标是将诊断能力扩展到
有利于及时诊断伤害,减轻伤害负担。研究假设是实施一种
提供者执行的SBU计划是扩大获得诊断成像的一种可行而有效的方法
为喀麦隆的创伤患者准备的。为了达到这一目标,这项研究将追求三个具体目标
R21阶段:1)评估SBU短期和中期技能培训课程的教育效果
和喀麦隆创伤提供者的知识获取;2)评估提供者的可行性--
在喀麦隆进行SBU试点;3)评估喀麦隆创伤中SBU试点的可接受性
利益相关者。如果达到R21过渡里程碑,R33阶段将实现三个具体目标:1)
评估提供者进行的SBU对创伤患者诊断的准确性;2)评估
提供者执行SBU计划,以扩大创伤诊断能力;3)测试之间的关联
SBU计划的实施和创伤结果。验证SBU是一种可行和有效的方法
扩大诊断能力将消除促使创伤护理的主要障碍,并提供关键目标
以减少伤害对这一人群的有害影响。学习方法中嵌入的是培训
喀麦隆临床医生参与卫生系统研究和加强移动健康能力,这将
支持卫生部门的开发和研究。标准化的SBU培训和实施
议定书可以迅速扩大,以便在整个喀麦隆更广泛地实施,并在其他国家得到验证
LMIC环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alain Mefire Chichom其他文献
Alain Mefire Chichom的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alain Mefire Chichom', 18)}}的其他基金
Harnessing Data Science to Promote Equity in Injury and Surgery for Africa
利用数据科学促进非洲伤害和手术的公平
- 批准号:
10659043 - 财政年份:2021
- 资助金额:
$ 16.65万 - 项目类别:
Harnessing Data Science to Promote Equity in Injury and Surgery for Africa
利用数据科学促进非洲伤害和手术的公平
- 批准号:
10314099 - 财政年份:2021
- 资助金额:
$ 16.65万 - 项目类别:
Strengthening the Quantitative Pipeline for Multidisciplinary Trauma Research in Cameroon
加强喀麦隆多学科创伤研究的定量渠道
- 批准号:
10490444 - 财政年份:2021
- 资助金额:
$ 16.65万 - 项目类别:
Strengthening the Quantitative Pipeline for Multidisciplinary Trauma Research in Cameroon
加强喀麦隆多学科创伤研究的定量渠道
- 批准号:
10673814 - 财政年份:2021
- 资助金额:
$ 16.65万 - 项目类别:
Strengthening the Quantitative Pipeline for Multidisciplinary Trauma Research in Cameroon
加强喀麦隆多学科创伤研究的定量渠道
- 批准号:
10394639 - 财政年份:2021
- 资助金额:
$ 16.65万 - 项目类别:
Harnessing Data Science to Promote Equity in Injury and Surgery for Africa
利用数据科学促进非洲伤害和手术的公平
- 批准号:
10490355 - 财政年份:2021
- 资助金额:
$ 16.65万 - 项目类别:
Harnessing Data Science to Promote Equity in Injury and Surgery for Africa
利用数据科学促进非洲伤害和手术的公平
- 批准号:
10842514 - 财政年份:2021
- 资助金额:
$ 16.65万 - 项目类别:
A Mobile Phone-based Triage Tool to Identify Discharged Trauma Patients in Need of Further Care in Cameroon
基于手机的分诊工具可识别喀麦隆需要进一步护理的出院创伤患者
- 批准号:
10473617 - 财政年份:2018
- 资助金额:
$ 16.65万 - 项目类别:
Building Capacity for Trauma Quality Improvement: An Innovative Pilot Program in Cameroon to Address the Burden of Injury
提高创伤质量的能力建设:喀麦隆解决伤害负担的创新试点计划
- 批准号:
9766432 - 财政年份:2018
- 资助金额:
$ 16.65万 - 项目类别:
相似海外基金
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 16.65万 - 项目类别:
Operating Grants
The effectiveness of oral cannabis extracts for osteoarthritic pain: an internal pilot, placebo controlled, blinded randomized trial
口服大麻提取物对骨关节炎疼痛的有效性:一项内部试点、安慰剂对照、盲法随机试验
- 批准号:
479511 - 财政年份:2023
- 资助金额:
$ 16.65万 - 项目类别:
Operating Grants
IMPACT, a supervised rehabilitation program for spastic ataxias: A rater-blinded, randomized controlled trial
IMPACT,痉挛性共济失调的监督康复计划:一项评估者盲法、随机对照试验
- 批准号:
468464 - 财政年份:2022
- 资助金额:
$ 16.65万 - 项目类别:
Operating Grants
Lineup construction methods: Should lineup constructors be blinded to the suspect?
阵容构建方法:阵容构建者是否应该对嫌疑人视而不见?
- 批准号:
2754233 - 财政年份:2022
- 资助金额:
$ 16.65万 - 项目类别:
Studentship
ZZ-3K3A-301: A multicenter, randomized, placebo-controlled, double-blinded, Phase 3 study to evaluate the efficacy and safety of 3K3A-APC (RHAPSODY-2)
ZZ-3K3A-301:一项多中心、随机、安慰剂对照、双盲、3 期研究,旨在评估 3K3A-APC (RHAPSODY-2) 的有效性和安全性
- 批准号:
10305528 - 财政年份:2022
- 资助金额:
$ 16.65万 - 项目类别:
Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Vortioxetine for Cognitive Deficits in Persons with Post-COVID-19 Condition
评估沃替西汀对 COVID-19 后患者认知缺陷的随机、双盲、安慰剂对照研究
- 批准号:
467059 - 财政年份:2021
- 资助金额:
$ 16.65万 - 项目类别:
Studentship Programs
Blinded Comparison of Different Alpha-Synuclein Seeding Assays as Cutaneous Biomarkers of Lewy Body Dementias
不同 α-突触核蛋白接种测定作为路易体痴呆皮肤生物标志物的盲法比较
- 批准号:
10458459 - 财政年份:2021
- 资助金额:
$ 16.65万 - 项目类别:
Blinded Comparison of Different Alpha-Synuclein Seeding Assays as Cutaneous Biomarkers of Lewy Body Dementias
不同 α-突触核蛋白接种测定作为路易体痴呆皮肤生物标志物的盲法比较
- 批准号:
10674759 - 财政年份:2021
- 资助金额:
$ 16.65万 - 项目类别:
Blinded Comparison of Different Alpha-Synuclein Seeding Assays as Cutaneous Biomarkers of Lewy Body Dementias
不同 α-突触核蛋白接种测定作为路易体痴呆皮肤生物标志物的盲法比较
- 批准号:
10064563 - 财政年份:2021
- 资助金额:
$ 16.65万 - 项目类别:
Discontinuation of levothyroxine therapy for patients with subclinical hypothyroidism: a pilot randomized, double-blinded, placebo-controlled study
亚临床甲状腺功能减退症患者停止左旋甲状腺素治疗:一项随机、双盲、安慰剂对照试验研究
- 批准号:
10184448 - 财政年份:2021
- 资助金额:
$ 16.65万 - 项目类别: